N-Methyl-3,4-methylenedioxyamphetamine

Displaying 1 - 4 of 4CSV
Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-78736-1
Publication Date
Palamar, J. J., Le, A., Rutherford, C., & Keyes, K. M. (2022). Exploring Potential Bellwethers for Drug-Related Mortality in the General Population: A Case for Sentinel Surveillance of Trends in Drug Use among Nightclub/Festival Attendees. Substance Use and Misuse, 58(2), 188–197. https://doi.org/10.1080/10826084.2022.2151315
Publication Date
Livne, O., Shmulewitz, D., Walsh, C., & Hasin, D. S. (2022). Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP. Addiction, 117(12), 3099–3109. Portico. https://doi.org/10.1111/add.15987
Publication Date
Palamar, J. J., Rutherford, C., Cleland, C. M., & Keyes, K. M. (2022). Concerts, Bars, Parties, and Raves: Differential Risk for Drug use among High School Seniors According to Venue Attendance. Substance Abuse, 43(1), 785–791. https://doi.org/10.1080/08897077.2021.2010253
Publication Date